Corneal Ulcer: Clinical Trials

55 trials for Corneal Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 12 unknown, 5 recruiting, 5 withdrawn. 16 Not applicable, 11 Phase 2, 9 Phase 3, 5 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 8, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 1
Phase 211Completed 5, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 39Completed 5, Recruiting 2, Unknown 2
Phase 15Completed 4, Withdrawn 1
Phase 43Completed 2, Withdrawn 1
Early Phase 12Completed 1, Unknown 1

Follow Corneal Ulcer: new trials by email Literature Review of Corneal Ulcer trials Research Report on Corneal Ulcer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluorometholone Study
Adjunctive Topical Fluorometholone (FML) 0.1%, Standard Topical Antibiotic Therapy - Keratitis Bacterial, Corneal Ulcer (Diagnosis)
Phase 2Not yet recruitingVishal Jhanji1742026-10-312026-06-10
Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder
SMS reminder - Corneal Ulcer
Not applicableRecruitingSeva Canada Society3102026-02-232026-05-12
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Intrastromal moxifloxacin injection plus standard topical moxifloxacin therapy, Standard topical moxifloxacin therapy alone - Bacterial Keratitis, Recalcitrant Infectious Keratitis
Not applicableRecruitingMinia University602025-10-012026-09-10
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Cyclosporine A, Placebo Comparator: Placebo - Fungal Keratitis, Corneal Ulcer
Phase 3RecruitingUniversity of California, San Francisco1502025-09-012026-06-05
Diagnosing Corneal Infection
Corneal impression membrane (Millicell Cell Culture Insert, 12mm, hydrophilic PTFE 0.4µm (PICM01250)) - Corneal Ulcer (Diagnosis)
WithdrawnUniversity of Edinburgh2025-02-012026-02-27
Parasitic Ulcer Treatment Trial
Polyhexamethylene biguanide (PHMB), Topical corticosteroid, Topical placebo - Acanthamoeba Keratitis
Phase 3RecruitingJeremy Keenan, MD, MPH2322024-07-012026-10-01
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
OXERVATE® 0.002% - Neurotrophic Keratitis, Neurotrophic Keratopathy
Phase 4WithdrawnDompé Farmaceutici S.p.A2024-04-262024-12-02
Studying the Effect of Ethanol Applied on the Corneal Surface During PRK Surgery.
Corneal Ulcer of Bilateral Eyes
CompletedMinia University702024-03-052024-08-06
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Mesenchymal Stromal Cells, Control Solution - Corneal Ulcer
Phase 2RecruitingUniversity of Illinois Chicago382023-09-292026-11-04
Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
rapid acting insulin - Corneal Ulcer, Neurotrophic Corneal Ulcer
UnknownBenha University302023-07-152023-07-11
AONDA Therapeutic Indication Study I
Lotrafilcon A contact lenses - Bullous Keratopathy, Corneal Erosion
CompletedAlcon Research552023-06-282023-07-20
Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases
PRF membrane tamponade surgery in macular hole, ILM peeling in macular hole, PRF membrane grafting in pterygium - Platelet-rich Fibrin, Macular Holes
Not applicableUnknownLei Du1702023-01-012024-01-12
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
LV-Visio-AMTRIX - Corneal Ulcer, Persistent Corneal Epithelial Defect
Phase 2WithdrawnTBF Genie Tissulaire2022-04-012022-08-05
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
Acyclovir, Tobramycin, Fluorometholone - Corneal Ulcer
UnknownSohag University402022-03-182022-04-06
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer
Phase 2 / Phase 3UnknownPeschke GmbH4882022-03-142022-10-28
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care Therapy + Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer
Phase 2 / Phase 3UnknownPeschke GmbH4682022-03-142022-10-28
Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis
Hollow gold and silver alloy cuprous oxide shell nano-shell hydrogel, Voriconazole eye drops, Normal saline - Keratitis, Ulcerative, Antibiotic Resistance, Microbial
Early Phase 1UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine202021-08-012022-03-07
Improving the Follow up Rate for Pediatric Patients
Counseling group, SMS and phone call reminder group - CNLDO - Congenital Nasolacrimal Duct Obstruction, Amblyopia
Not applicableCompletedSeva Foundation2642021-02-152022-03-10
The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer
Naltrexone Hydrochloride, Carboxy methyl cellulose - Cornea Ulcer
Not applicableCompletedMinia University502021-01-012023-06-29
Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers
Autologous platelet-rich plasma (PRP) eye drops - Cornea Ulcer
Phase 4CompletedAlaa Gamal142021-01-012022-08-25

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Keratitis (11)  ·  Corneal Diseases (6)  ·  Corneal Dystrophies, Hereditary (4)  ·  Eye Diseases (3)  ·  Pterygium (3)  ·  Bacterial Infections (2)  ·  Conjunctivitis (2)  ·  Corneal Opacity (2)  ·  Corneal Perforation (2)  ·  Disease (2)  ·  Eye Infections, Fungal (2)  ·  Mycoses (2)  ·  Ulcer (2)  ·  Acanthamoeba Keratitis (1)

Broader conditions

Infections (55)  ·  Eye Infections (54)  ·  Eye Diseases (52)  ·  Corneal Diseases (49)  ·  Keratitis (44)  ·  Conjunctival Diseases (6)  ·  Bacterial Infections and Mycoses (5)  ·  Nervous System Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Craniocerebral Trauma (4)  ·  Eye Diseases, Hereditary (4)  ·  Facial Injuries (4)  ·  Genetic Diseases, Inborn (4)  ·  Pathologic Processes (4)

Interventions

Riboflavin (4)  ·  Adrenal Cortex Hormones (2)  ·  Fluorometholone (2)  ·  Lubricant Eye Drops (2)  ·  Moxifloxacin (2)  ·  Natamycin (2)  ·  Ophthalmic Solutions (2)  ·  Voriconazole (2)  ·  cenegermin (2)  ·  Abortion, Induced (1)  ·  Acyclovir (1)  ·  Anti-Bacterial Agents (1)  ·  Anti-Inflammatory Agents (1)  ·  Biological Dressings (1)  ·  Corneal Cross-Linking (1)

Sponsors

University of California, San Francisco (6)  ·  Minia University (3)  ·  Dompé Farmaceutici S.p.A (2)  ·  National Taiwan University Hospital (2)  ·  Peschke GmbH (2)  ·  TBF Genie Tissulaire (2)  ·  ACRO Biomedical Co. Ltd (1)  ·  Alaa Gamal (1)  ·  Alcon Research (1)  ·  Aravind Eye Care System (1)  ·  Asia Cornea Society (1)  ·  Benha University (1)  ·  Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. (1)  ·  Chulalongkorn University (1)  ·  Cornea Consultants Of Nashville (1)

Countries

United States (19)  ·  India (9)  ·  Egypt (7)  ·  China (5)  ·  France (5)  ·  Nepal (4)  ·  Taiwan (4)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Germany (2)  ·  Thailand (2)  ·  Belarus (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Bala Ambati (2)  ·  NV Prajna, DNB, FRC Ophth (2)  ·  Nisha Acharya, MD, MS (2)  ·  Tom Lietman, MD (2)  ·  Yvette Viscuso (2)  ·  Ahmed Gomaa (1)  ·  Ali R Djalilian, MD (1)  ·  Andres Garralda Luquin, MD (1)  ·  Andreza Werli-Alvarenga, RN, MD, PhD (1)  ·  Brad Kligman, MD (1)  ·  Carlos Lopez Gutierrez, MD (1)  ·  Charlotte E Joslin, OD, PhD (1)  ·  Christophe Baudouin, MD (1)  ·  Danielle Robertson, OD, PhD (1)

Results publications

PMID 32557558, PMID 34483270, PMID 35024776, PMID 10832689, PMID 11285665, PMID 11520759, PMID 12131029, PMID 12386069, PMID 12515932, PMID 15355406, PMID 15829742, PMID 16575115, PMID 16926355, PMID 17258535, PMID 17657018, PMID 18204773, PMID 18245962, PMID 18608899, PMID 18829631, PMID 19097643, PMID 1985498, PMID 20847116, PMID 20944931, PMID 21836342, PMID 21987582, PMID 22159005, PMID 22395880, PMID 22447793, PMID 22959881, PMID 23062001, PMID 23307105, PMID 23385795, PMID 23702779, PMID 24315294, PMID 24612976, PMID 24618327, PMID 25764482, PMID 25955359, PMID 2597070, PMID 26448169, PMID 26531051, PMID 27054515, PMID 27631025, PMID 27787540, PMID 28426856, PMID 28579539, PMID 28817744, PMID 30025986, PMID 31619359, PMID 33031809

NIH funding

U10EY018573 (2), R01EY031033 (1), U10EY015114 (1), U10EY022880 (1), UG1EY033284 (1)